share_log

BRIEF-NRX Pharmaceuticals Entered Into Shareholder Agreement With Shimshon Hen And David Sepiashvili

BRIEF-NRX Pharmaceuticals Entered Into Shareholder Agreement With Shimshon Hen And David Sepiashvili

简介-NRX制药公司与Shimshon Hen和David Sepiashvili达成股东协议
reuters ·  2021/10/21 17:33

Oct 21 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :

路透10月21日电-NRX制药公司NRXP.O：

* NRX PHARMACEUTICALS INC - ENTERED INTO A SHAREHOLDER AGREEMENT WITH SHIMSHON HEN AND DAVID SEPIASHVILI

*NRX制药公司-与Shimshon Hen和David Sepiashvili达成股东协议

* NRX PHARMACEUTICALS INC - AGREEMENT FOR NEW JV BETWEEN CO AND SHAREHOLDERS FOR DEVELOPMENT AND COMMERCIALIZATION OF BRILIFE VACCINE

*NRX制药公司-CO和股东就BRILIFE疫苗的开发和商业化达成的新合资企业协议

* NRX PHARMACEUTICALS INC - AGREEMENT PROVIDES THAT COMPANY WILL HOLD 60% OF EQUITY INTEREST IN VACCINECO WITH SHAREHOLDERS HOLDING REMAINING 40%

*NRX制药公司-协议规定，公司将持有VACCINECO 60%的股权，股东持有剩余的40%

* NRX PHARMACEUTICALS INC - VACCINECO EXPECTED TO HAVE A FOUR-MEMBER BOARD OF DIRECTORS, CO & SHAREHOLDERS WILL EACH BE ENTITLED TO APPOINT 2 MEMBERS

*NRX制药公司-VACCINECO预计将有一个四人董事会，CO和股东每人将有权任命2名成员

Source text for Eikon: [ Further company coverage: NRXP.O

Eikon的源文本：[进一步的公司报道：NRXP.O

((Reuters.Briefs@thomsonreuters.com;))

(Reurs.Briefs@thomsonreurs.com；)

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发